Inventor
SCHILLING STEPHAN
DE33 patents
⚠️ This page may combine multiple inventors who share the name “SCHILLING STEPHAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PROBIODRUG AG
14 patentsUS7381537B2Jun 3, 2008
Use of inhibitors of glutaminyl cyclases for treatment and prevention of disease
PROBIODRUG AG62 citations97
US7371871B2May 13, 2008
Inhibitors of glutaminyl cyclase
PROBIODRUG AG90 citations97
US7304086B2Dec 4, 2007
Inhibitors of glutaminyl cyclase
PROBIODRUG AG64 citations97
US7732162B2Jun 8, 2010
Inhibitors of glutaminyl cyclase for treating neurodegenerative diseases
PROBIODRUG AG51 citations96
US7462599B2Dec 9, 2008
Use of effectors of glutaminyl and glutamate cyclases
PROBIODRUG AG31 citations92
US10603367B2Mar 31, 2020
Humanized antibodies
PROBIODRUG AG2 citations70
US7655684B2Feb 2, 2010
Inhibitors of glutaminyl cyclase
PROBIODRUG AG2 citations62
US11045533B2Jun 29, 2021
Humanized antibodies
PROBIODRUG AG0 citations59
US7897633B2Mar 1, 2011
Inhibitors of glutaminyl cyclase
PROBIODRUG AG0 citations51
US9157918B2Oct 13, 2015
Antibodies directed against pyroglutamate monocyte chemoattractant protein-1 (MCP-1 N1pE)
PROBIODRUG AG0 citations50
US9657089B2May 23, 2017
Diagnostic antibody assay
PROBIODRUG AG0 citations48
US9277737B2Mar 8, 2016
Mouse models carrying a knock-out mutation of the QPCTL-gene
PROBIODRUG AG0 citations48
US9676843B2Jun 13, 2017
Uses of antibodies directed against amyloid-β
PROBIODRUG AG0 citations47
US8859250B2Oct 14, 2014
Crystal structure of glutaminyl cyclase
PROBIODRUG AG0 citations46
SCHILLING STEPHAN
7 patentsUS8129160B2Mar 6, 2012
Method of screening for inhibitors of glutaminyl cyclase activity
SCHILLING STEPHAN7 citations82
US8283517B2Oct 9, 2012
Transgenic mouse models of Aβ overexpression
SCHILLING STEPHAN6 citations78
US8409837B2Apr 2, 2013
Crystal structure of glutaminyl cyclase
SCHILLING STEPHAN5 citations77
US8338120B2Dec 25, 2012
Method of treating inflammation with glutaminyl cyclase inhibitors
SCHILLING STEPHAN5 citations60
US8647834B2Feb 11, 2014
Screening method for enzyme inhibitors
SCHILLING STEPHAN2 citations57
US9462793B2Oct 11, 2016
Mouse carrying a knock-out mutation of the Qpct-gene
SCHILLING STEPHAN0 citations51
US8470781B2Jun 25, 2013
Use of effectors of glutaminyl and glutamate cyclases
SCHILLING STEPHAN0 citations51
DEMUTH HANS-ULRICH
4 patentsUS8058405B2Nov 15, 2011
Antibodies specific for N-terminal truncated and pyroglutamate modified amyloid-beta peptides
DEMUTH HANS-ULRICH38 citations92
US8889709B2Nov 18, 2014
Use of isoQC inhibitors in the treatment and prevention of inflammatory diseases or conditions
DEMUTH HANS-ULRICH4 citations68
US8685664B2Apr 1, 2014
Use of inhibtors of glutaminyl cyclases for treatment and prevention of disease
DEMUTH HANS-ULRICH0 citations51
US9156907B2Oct 13, 2015
Diagnostic antibody assay
DEMUTH HANS-ULRICH0 citations48